All Stories

  1. HIV cure: global overview of bNAbs’ patents and related scientific publications

    Article • Expert Opinion on Therapeutic Patents, July 2018, Taylor & Francis

    Dr Reinaldo M Martins, Adelaide maria de souza antunes

  2. Duration of post-vaccination immunity to yellow fever in volunteers eight years after a dose-response study

    Article • Vaccine, June 2018, Elsevier

    Dr Reinaldo M Martins

  3. Zika puzzle in Brazil: peculiar conditions of viral introduction and dissemination - A Review

    Article • Memórias do Instituto Oswaldo Cruz, May 2017, FapUNIFESP (SciELO)

    Dr Reinaldo M Martins

  4. Neonatal infections: Case definition and guidelines for data collection, analysis, and presentation of immunisation safety data

    Article • Vaccine, December 2016, Elsevier

    Dr Reinaldo M Martins, Dr Sonali Kochhar

  5. Yellow fever vaccine supply: a possible solution

    Article • The Lancet, April 2016, Elsevier

    Dr Reinaldo M Martins

  6. Booster dose after 10 years is recommended following 17DD-YF primary vaccination

    Article • Human Vaccines & Immunotherapeutics, September 2015, Taylor & Francis

    Dr Reinaldo M Martins

  7. A randomised double-blind clinical trial of two yellow fever vaccines prepared with substrains 17DD and 17D-213/77 in children nine-23 months old

    Article • September 2015, FapUNIFESP (SciELO)

    Dr Reinaldo M Martins

  8. Serious adverse events associated with yellow fever vaccine

    Article • Human Vaccines & Immunotherapeutics, June 2015, Taylor & Francis

    Dr Reinaldo M Martins

  9. Access to new technologies in multipatented vaccines: challenges for Brazil

    Article • Nature Biotechnology, June 2015, Nature

    Dr Reinaldo M Martins

  10. Immunogenicity and safety of measles–mumps–rubella vaccine delivered by disposable-syringe jet injector in healthy Brazilian infants: A randomized non-inferiority study

    Article • Contemporary Clinical Trials, March 2015, Elsevier

    Dr Reinaldo M Martins

  11. Historical review of clinical vaccine studies at Oswaldo Cruz Institute and Oswaldo Cruz Foundation - technological development issues

    Article • Memórias do Instituto Oswaldo Cruz, February 2015, FapUNIFESP (SciELO)

    Dr Reinaldo M Martins

  12. Adverse events following yellow fever immunization: Report and analysis of 67 neurological cases in Brazil

    Article • Vaccine, November 2014, Elsevier

    Dr Reinaldo M Martins

  13. Immune response to the mumps component of the MMR vaccine in the routine of immunisation services in the Brazilian National Immunisation Program

    Article • Memórias do Instituto Oswaldo Cruz, June 2014, FapUNIFESP (SciELO)

    Dr Reinaldo M Martins

  14. Subdoses of 17DD yellow fever vaccine elicit equivalent virological/immunological kinetics timeline

    Article • BMC Infectious Diseases, January 2014, Springer Science + Business Media

    Dr Reinaldo M Martins

  15. Vaccine research, development, and innovation in Brazil: A translational science perspective

    Article • Vaccine, April 2013, Elsevier

    Dr Reinaldo M Martins

  16. 17DD yellow fever vaccine

    Article • Human Vaccines & Immunotherapeutics, April 2013, Taylor & Francis

    Dr Reinaldo M Martins

  17. Safety and immunogenicity of meningococcus C conjugate vaccine

    Article • January 2013, Springer Science + Business Media

    Dr Reinaldo M Martins

  18. 17DD and 17D-213/77 Yellow Fever Substrains Trigger a Balanced Cytokine Profile in Primary Vaccinated Children

    Article • PLoS ONE, December 2012, PLOS

    Dr Reinaldo M Martins

  19. Yellow fever vaccine dose-response study

    Article • December 2012, Springer Science + Business Media

    Dr Reinaldo M Martins

  20. Immunogenicity and safety of a Meningococcus B Brazilian vaccine

    Article • December 2012, Springer Science + Business Media

    Dr Reinaldo M Martins

  21. Viscerotropic disease: Case definition and guidelines for collection, analysis, and presentation of immunization safety data

    Article • Vaccine, July 2012, Elsevier

    Dr Joaquim Gascon, Dr Reinaldo M Martins

  22. Cytokine Signatures of Innate and Adaptive Immunity in 17DD Yellow Fever Vaccinated Children and Its Association With the Level of Neutralizing Antibody

    Article • The Journal of Infectious Diseases, August 2011, Oxford University Press (OUP)

    Dr Reinaldo M Martins

  23. Mutual interference on the immune response to yellow fever vaccine and a combined vaccine against measles, mumps and rubella

    Article • Vaccine, August 2011, Elsevier

    Dr Reinaldo M Martins

  24. Atualização em vacinas, imunizações e inovação tecnológica

    Article • Ciência & Saúde Coletiva, February 2011, FapUNIFESP (SciELO)

    Dr Reinaldo M Martins

  25. WHO Working Group on Technical Specifications for Manufacture and Evaluation of Yellow Fever Vaccines, Geneva, Switzerland, 13–14 May 2009

    Article • Vaccine, December 2010, Elsevier

    Dr Reinaldo M Martins

  26. Yellow Fever Vaccine Post-marketing Surveillance in Brazil

    Article • Procedia in Vaccinology, January 2010, Elsevier

    Dr Reinaldo M Martins

  27. Clinical and Immunological Insights on Severe, Adverse Neurotropic and Viscerotropic Disease following 17D Yellow Fever Vaccination

    Article • Clinical and Vaccine Immunology, November 2009, ASM Journals

    Dr Reinaldo M Martins

  28. Immunogenicity, reactogenicity and consistency of production of a Brazilian combined vaccine against diphtheria, tetanus, pertussis and Haemophilus influenzae type b

    Article • Memórias do Instituto Oswaldo Cruz, November 2008, FapUNIFESP (SciELO)

    Dr Reinaldo M Martins

  29. Incidência de episódios hipotônicos-hiporresponsivos associados à vacina combinada DTP/Hib usada no Programa Nacional de Imunizações

    Article • Jornal de Pediatria, December 2007, FapUNIFESP (SciELO)

    Dr Reinaldo M Martins

  30. Incidence of hypotonic-hyporesponsive episodes associated to the combined DTP/Hib vaccine used in Brazilian National Immunizations Program

    Article • Jornal de Pediatria, November 2007, Jornal de Pediatria

    Dr Reinaldo M Martins

  31. Hypotonic-hyporesponsive episode (HHE) as an adverse event following immunization in early childhood: Case definition and guidelines for data collection, analysis, and presentation

    Article • Vaccine, August 2007, Elsevier

    Dr Reinaldo M Martins

  32. The sample processing time interval as an influential factor in flow cytometry analysis of lymphocyte subsets

    Article • Memórias do Instituto Oswaldo Cruz, February 2007, FapUNIFESP (SciELO)

    Dr Reinaldo M Martins

  33. Yellow fever vaccination: Some thoughts on how much is enough [Vaccine 23 (2005) 3908–3914]

    Article • Vaccine, January 2007, Elsevier

    Dr Reinaldo M Martins

  34. Multicenter study on the immunogenicity and safety of two recombinant vaccines against hepatitis B

    Article • Memórias do Instituto Oswaldo Cruz, December 2004, FapUNIFESP (SciELO)

    Dr Reinaldo M Martins

  35. Estudo multicêntrico de imunogenicidade e reatogenicidade de vacinas contra hepatite B: informe preliminar

    Article • Epidemiologia e Serviços de Saúde, September 2003, Instituto Evandro Chagas

    Dr Reinaldo M Martins

  36. Eventos adversos pós-vacinais e resposta social

    Article • História Ciências Saúde-Manguinhos, January 2003, FapUNIFESP (SciELO)

    Dr Reinaldo M Martins

  37. Desenvolvimento tecnológico: elo deficiente na inovação tecnológica de vacinas no Brasil

    Article • História Ciências Saúde-Manguinhos, January 2003, FapUNIFESP (SciELO)

    Dr Reinaldo M Martins

  38. Varicella: clinical aspects and prevention

    Article • Jornal de Pediatria, July 1999, Jornal de Pediatria

    Dr Reinaldo M Martins

  39. Missed opportunities for immunization

    Article • Jornal de Pediatria, January 1996, Jornal de Pediatria

    Dr Reinaldo M Martins

  40. Haemophilus influenzae type b infections and its prevention by vaccines

    Article • Jornal de Pediatria, July 1994, Jornal de Pediatria

    Dr Reinaldo M Martins

  41. Disposable-Syringe Jet Injector for Measles-Mumps-Rubella vaccine (DSJI MMR) study

    Article • Springer Science + Business Media

    Dr Reinaldo M Martins

  42. Immunogenicity and safety of combined vaccine against diphtheria, tetanus, pertussis and haemophilus influenzae type B: clinical validation of a product totally produced in Brazil

    Article • Springer Science + Business Media

    Dr Reinaldo M Martins